suziemarshall

13 POSTS 0 COMMENTS

LivaNova enrols first patient in RECOVER clinical study

RECOVER
LivaNova has announced the first patient enrolled in their RECOVER trial, a prospective, multi-centre, randomised controlled blinded trial demonstrating the safety and effectiveness of...

Surface modification technology could revolutionise ruptured aneurysm treatment globally

Laurent Pierot (Reims, France) talks to BLearning Neuro at ESMINT 2019 (European Society of Minimally Invasive Neurological Therapy; 4–6 September; Nice, France) about the HPC (Hydrophilic Polymer Coating)...

MRI Interventions reaches ClearPoint milestone

ClearPoint
MRI Interventions said its ClearPoint Neuro navigation system has been used in 3,000 neurosurgical procedures. The milestone procedure was completed at the University of California,...

Scott Gottlieb resigns as head of US FDA

The commissioner of the US Food and Drug Administration (FDA), Scott Gottlieb, has unexpectedly resigned after serving just shy of two years in the...

Acute ischaemic stroke care continuum: With stroke patients every step of...

medtronic
The fact that endovascular therapy is now well established for patients with acute ischaemic stroke has changed the face of stroke treatment forever. The last five...

US government shutdown disrupting FDA work

shutdown
The US government shutdown means the country’s Food and Drug Administration (FDA) cannot accept new user fees, which means the agency cannot accept new...

Balt announces receiving CE mark for Magic Glue, a next generation...

Balt International has announced receiving the CE mark for Magic Glue, its next generation of cyanoacrylate liquid embolic agent. Magic Glue is indicated for...

Addressing patient variability and the dynamic nature of pain: The value...

With a series of new products this year and the acquisition of Cosman Medical’s radiofrequency portfolio, Boston Scientific continues to drive forward as a...

Nevro receives TGA approval for Senza II spinal cord stimulation system...

Senza
The Therapeutic Goods Administration (TGA) has granted approval to Nevro for its next-generation Senza II spinal cord stimulation system delivering the company’s proprietary HF10...

International neurointerventional societies outline new criteria for facilities that treat stroke

  Thirteen neurointerventional societies have released new guidelines outlining the criteria for Level 1, 2 and 3 stroke centres that provide acute ischemic stroke interventions...

Mainstay Medical announces the completion of all implants in the ReActiv8-B...

Mainstay Medical International, a medical device company focused on bringing to market ReActiv8, an implantable neurostimulation system to treat chronic low back pain, announces...

NSI-566 stem cell therapy confers neurological improvement in spinal cord injury...

Stem cells
Intraspinal injections of human spinal cord-derived neural stem cells are well tolerated in a Phase I study of four patients with thoracic (T2–T12) ASIA-A...

FDA releases final rule on acceptance of data from clinical investigations...

The Food and Drug Administration (FDA) has today issued the final rule on “human subject protection; acceptance of data from clinical investigations for medical...